Amy Simon serves as Executive at Beam Therapeutics Inc., where they oversee executive responsibilities. Since joining the company, Amy Simon has executed 13 insider transactions totaling $1.3M, demonstrating a bearish approach to their equity position. Their most recent transaction on Jul 3, 2025 involved selling 876 shares valued at $17.6K.
Amy Simon currently holds 64,864 shares of Beam Therapeutics Inc. (BEAM), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Amy Simon has been a net seller of BEAM stock. They have purchased $0 and sold $1.3M worth of shares.
Amy Simon's most recent insider trade was on Jul 3, 2025, when they sold 876 shares at $20.12 per share.
Get notified when new Form 4 filings are submitted
| $16.94 |
| Discretionary |
| Jul 2, 2024 | BEAM | $17.2K | Sale | 748 | $22.95 | Planned |
| Jul 1, 2024 | BEAM | $11.9K | Sale | 502 | $23.76 | Planned |
| Apr 2, 2024 | BEAM | $504.8K | Sale | 16,530 | $30.54 | Planned |
| Apr 1, 2024 | BEAM | $230.0K | Sale | 7,157 | $32.13 | Planned |
| Mar 31, 2024 | BEAM | $0 | Award | 27,500 | $N/A | Discretionary |
| Oct 30, 2023 | BEAM | $64.5K | Sale | 3,448 | $18.70 | Planned |
| Jul 10, 2023 | BEAM | $11.9K | Sale | 391 | $30.48 | Planned |
| Apr 4, 2023 | BEAM | $33.8K | Sale | 1,161 | $29.09 | Planned |
| Apr 4, 2023 | BEAM | $312.4K | Sale | 10,493 | $29.77 | Planned |
| Apr 3, 2023 | BEAM | $134.7K | Sale | 4,445 | $30.31 | Planned |
| Mar 31, 2023 | BEAM | $0 | Award | 20,000 | $N/A | Discretionary |